Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.8000 (0.69%) ($5.5000 - $5.8900) on Tue. Apr. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.2% (three month average) | RSI | 56 | Latest Price | $5.8000(0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VXX(86%) PCY(12%) XBI(12%) EWY(10%) LIT(10%) | Factors Impacting CAPR price | CAPR will decline at least -3.1% in a week (0% probabilities). URA(-20%) XLE(-16%) XOP(-15%) USO(-15%) BLOK(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.1% (StdDev 6.2%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
5 Day Moving Average | $5.87(-1.19%) | 10 Day Moving Average | $5.75(0.87%) | 20 Day Moving Average | $5.63(3.02%) | To recent high | -14.7% | To recent low | 16% | Market Cap | $114m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |